Drug sharing among heroin networks: Implications for HIV and hepatitis B and C prevention

AIDS and Behavior

Volumn 9, Issue 1, 2005, Pages 27-39

  Koester, Stephen ^a   Glanz, Jason ^a   Barón, Anna ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Drug sharing; Hepatitis C; HIV; Injection drug users

Indexed keywords

ADULT; AGED; ARTICLE; BLEACHING; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HEROIN DEPENDENCE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; QUALITATIVE RESEARCH; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK REDUCTION; SAFETY; SYRINGE; VIRAL CONTAMINATION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AMPHETAMINE-RELATED DISORDERS; COCAINE-RELATED DISORDERS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS B; HEPATITIS C; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; NEEDLE SHARING; RISK FACTORS; SOCIAL ENVIRONMENT; SOCIAL IDENTIFICATION; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES;

EID: 17644424289     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-005-1679-y     Document Type: Article

References (66)

1. Blankenship, K., and Koester, S. (2002). Criminal law, policing policy, and HIV risks in street workers and injection drug users. Journal of Law, Medicine and Ethics, 30, 548-559.
2. Bluthenthal, R. N., and Watters, J. K. (1995). Multimethod research: From targeted sampling to HIV risk behaviors. In E. Y. Lambert, R. S. Ashery and R. H. Needle (Eds.), Qualitative Methods in the Prevention of Drug Abuse and HIV Research (pp 212-230). NIDA Research Monograph 157, Rockville, MD: National Institute on Drug Abuse.
3. Bourgois, P., Lettiere, M., and Quesada, J. (1997). Social misery and the sanctions of substance abuse: Confronting HIV risk among homeless heroin addicts in San Francisco. Social Problems, 44, 155-173.
4. Bourgois, P. (1999). Theory, method and power in drug and HIV-prevention research: A participant-observer's critique. Substance Use and Abuse, 3, 2155-2172.
5. Bourgois, P. (2002). Anthropology and epidemiology on drugs: The challenges of cross-methodological and theoretical dialogue. International Journal of Drug Policy, 13, 259-269.
6. Broadhead, R. S., Kerr, T. H., Grund, J. C., and Altice, F. L. (2002). Safer injection facilities in North America: Their place in public policy and health Initiatives. The Journal of Drug Issues, 329-355.
7. Burris, S., Donoghoe, M., Blankenship, K. M., Sherman, S., Vernick, J. S., Case, P., Lazzarini, Z., and Koester, S. (2004). Addressing the "risk environment" for injection drug users: The mysterious case of the missing cop. Milbank Quarterly, 82, 125-156
8. Carlson, R. G., Wang, J., Siegal, H. A., Falck, R. S., and Guo, J. (1994). An ethnographic approach to targeted sampling: Problems and solutions in AIDS prevention research among injection drug and crack cocaine users. Human Organization, 53, 279-286.
9. Carlson, R. G., Siegal, H. A., Wang, J., and Falck, R. S. (1996). Attitudes toward needle "Sharing" among injection drug users: Combining qualitative and quantitative research methods. Human Organization, 55, 361-369.
10. Carlson, R. G. (2000). Shooting galleries, dope houses, and injection doctors: Examining the social ecology of HIV risk behaviors among drug injectors in Dayton, Ohio. Human Organization, 59, 325-333.
11. Centers for Disease Control and Prevention, and the Academy for Educational Development (2000). A comprehensive approach: Preventing blood-borne infections among injection drug users.
12. Clatts, M. C., Heimer, R., Abdala, N., Goldsamt, L. A., Southeran, J. L., Anderson, K. T. Gallo, T. M., Hoffer, L. D., Luciano, P. A., and Kyriakides, T. (1999) HIV-1 transmission in injection paraphernalia: Heating drug solutions may inactivate HIV-1. The Journal of Acquired Immune Deficiency Svndromes, 22, 194-199.
13. Colón, H. M., Finlinson, H. A., Robles, R. R., Deren, S., Andía, I., Kang, S., and Oliver-Vélez, D. (2001). Joint drug purchases and drug preparation risk behaviors among Puerto Rican injection drug users. AIDS and Behavior, 5, 85-96.
14. Crofts, N., Caruana, S., Bowden, S., and Kerger, M. (2000). Minimising harm from hepatitis C virus needs better strategies. Letter. British Medical Journal, 321, 899.
15. Curtis, R., Friedman, S. R., Neaigus, A., Jose, B., Goldstein, M., and Ifdefonso, G. (1995). Street-level drug markets: Network structure and HIV risk. Social Networks, 17, 229-249.
16. Deren, S., Oliver-Velez, D., Finlinson, A., Robles, R., Andia, J., Colon, H. M., Kang, S. Y., and Shedlin, M. (2003). Integrating qualitative and quantitative methods: Comparing HIV-related risk behaviors among Puerto Rican drug users in Puerto Rico and New York. Substance Use and Misuse, 38, 1-24.
17. Des Jarlais, D. C. (2000). Structural interventions to reduce HIV transmission among injecting drug users. AIDS, 14, S41-46.
18. Finlinson, H. A., Oliver-Vélez, D., Cóacgr lon, H. M., Deren, S., Robles, R. R., Beardsley, M., Cant, J. G. H., Andía, J., and López, M. S. (2000). Syringe acquisition and use of syringe exchange programs by Puerto Rican drug injectors in New York and Puerto Rico: Comparisons based on quantitative and qualitative methods. AIDS and Behavior, 4, 341-351.
19. Finlinson, A., Colón, H. M., Soto López, M., Robles, R. R., and Cant, J. G. H. (2005). Injecting shared drugs: An observational study of the process of drug acquisition, preparation, and injection by Puerto Rican drug users. Journal of Psychoactive Drugs, 37(1).
20. Friedman, S. R., de Jong, W., and Wodak, A. (1993). Community development as a response to HIV among drug injectors. AIDS, 7, S263-S269.
21. Friedman, S. R., Neaigus, A., Jose, B., Curtis, R., Goldstein, M., Ildefonso, G., Rothenberg, R. B., and Des Jarlais, D. C. (1997). Sociometric risk networks and risk for HIV infection. American Journal of Public Health, 87, 1289-1296.
22. Friedman, S. R., Curtis, R., Neaigus, A., Jose, B., and Des Jarlais, D. C. (1999). Social Networks, Drug Injectors' Lives, and HIV/AIDS. New York: Kluwer Academic/Plenum Publishers.
23. Garfein, R. S., Doherty, M. C., Monterroso, E. R., Thomas, D. L., Nelson, K. E., and Vlahov, D. (1998). Prevalence and incidence of Hepatitis C virus infection among young adult injection drug users. Journal of the Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, S11-S19.
24. Grund, J., Kaplan, C., and Adriaans, N. (1991). Drug sharing and HIV transmission risks: The practice of frontloading in the Dutch injecting drug user population. Journal of Psychoactive Drugs, 23, 1-10.
25. Grund, J. C., Friedman, S. R., Stern, L. S., Jose, B., Neaigus, A., Curtis, R., and Des Jarlais, D. (1996). Syringe-mediated sharing among injecting drug users: Patterns, social context and implications for transmission of blood-borne pathogens. Social Science and Medicine, 42, 691-703.
26. Hahn, J. A., Page-Schafer, K., Lum, P. J., Bourgois, P., Stein, E., Evans, J. L., Busch, M. P., Tobler, L. H., Phelps, B., and Moss, A. R. (2002). Hepatitis C virus seroconversion among young injection drug users: Relationships and risks. Journal of Infectious Diseases, 186, 1558-1564.
27. Hagan, H., Thiede, H., Weiss, N. S., Hopkins, S. G., Duchin, J. S., and Alexander, E. R. (2001). Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health, 91, 42-46.
28. Hoffer, L. D. (2001). Junkie business: The evolution and operation of a heroin dealing network. Unpublished Ph.D. dissertation, University of Colorado at Denver.
29. Hosmer, D., and Lemeshow, S. (2000). Applied Logistic Regression, 2nd Edition. New York: John Wiley & Sons, Inc.
30. Inciardi, J. A., and Page, J. B. (1991). Drug sharing among intravenous drug users. AIDS, 5, 772-773.
31. Jose, B., Friedman, S. R., Neaigus, A., Curtis, R., Grund, J. C., Goldstein, M. F., Ward, T. P., and Des Jarlais, D. C. (1993). Syringe mediated drug sharing (backloading): A new risk factor for HIV among injecting drug users. AIDS, 7, 1653-1660.
32. Kleinbaum, D. G. (1998). Applied Regression Analysis and Other Multivariable Methods. Pacific Grove: Duxbury Press.
33. Klovdahl, A. S. (1985). Social networks and the spread of infectious diseases: The AIDS example. Social Science and Medicine, 21, 1203-1216.
34. Koester, S., Booth, R., and Weibel, W. (1990). The risk of HIV transmission from sharing water, drug-mixing containers and cotton filters among intravenous drug users. International Journal on Drug Policy, 1, 28-30.
35. Koester, S., and Hoffer, L. (1994). Indirect sharing: Additional risks associated with drug injection. AIDS and Public Policy, 9, 100-105.
36. Koester, S. (1998). Following the blood: Syringe re-use leads to blood-borne viral transmission among injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, S139.
37. Koester, S., Anderson, K., Hoffer, L., and Lauper, U. (1996a). Drug sharing implications for HIV prevention. Poster presented at the XI International Conference on AIDS, Vancouver, British Columbia. July 9.
38. Koester, S., Booth, R., and Zhang, Y. (1996b). The prevalence of additional injection related HIV risk behaviors among injection drug users. The Journal of Acquired Immune Deficiency Svndromes, 2, 202-207.
39. Koester, S., Heimer, R., Barón, A., Glanz, J., and Wei, M. (2003). RE: "The risk of hepatitis C virus among young adult injection drug users who share injection equipment." Letter. American Journal of Epidemiology, 157, 357.
40. Koester, S. (1994). Copping, running, and paraphernalia laws: Contextual variables and needle Risk behavior among injection drug users in Denver. Human Organization, 53, 287-295.
41. Koester, S., Bush, T., and Lewis, B. (2002). Limited access to syringes for injection drug users in pharmacies in Denver, Colorado. Journal of the American Pharmaceutical Association, 42, S88-S91.
42. Latkin, C. A., Mandell, W., Vlahov, D., Oziemkowska, M., and Celentano, D. D. (1995). Personal network characteristics as antecedents to needle sharing and shooting gallery attendance. Social Networks, 17, 219-28.
43. Maher, L., and Dixon, D. (1999). Policing and public health. British Journal of Criminology, 39, 488-512.
44. Maher, L. (2002). Don't leave us this way: Ethnography and injecting drug use in the age of AIDS. International Journal of Drug Policy, 13, 311-325.
45. McCoy, C. B., and Inciardi, J. A. (1995). Sex, drugs, and the continuing spread of AIDS. Los Angeles: Roxbury Publishing.
46. Neaigus, A., Friedman, S. R., Curtis, R., Des Jarlais, D. C., Furst, R. T., Jose, B., Mota, P., Stepherson, B., Sufian, M., Ward, T., and Wright, J. W. (1994). The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. Social Science and Medicine, 38, 67-78.
47. Neaigus, A. (1998). The Network approach and interventions to prevent HIV among injection drug users. Public Health Reports, 113, 140-150.
48. Needle, R. H., Coyle, S., Cesari, H., Trotter, R., Clatts, M., Koester, S., Price, L., McLellan, E., Finlinson, A., Bluthenthal, R. N., Pierce, T., Johnson, J., Jones, T. S., and Williams, M. (1998). HIV risk behaviors associated with multiperson use of drug paraphernalia in injection drug user networks. Substance Use and Misuse, 33, 2403-2423.
49. Quellet, L. J., Jimenez, A. D., Johnson, W. A., and Wiebel, W. W. (1991). Shooting galleries and HIV disease: Variations in places for injecting illicit drugs. Crime and Delinquency, 37, 64-85.
50. Page, J. B., Chitwood, D. D., Smith, P. C., Kane, N., and McBride, D. C. (1990). Intravenous drug use and HIV infection in Miami. Medical Anthropology Quarterly, 4, 56-71.
51. Page, J. B. (1990). Shooting scenarios and risk of HIV 1 infection. American Behavioral Scientist, 33, 478-490.
52. Page, J. B., and Fraile, S. (1999). Use of needles and syringes in Miami and Valencia: Observations of high and low availability. Medical Anthropology Quarterly, 13, 413-435.
53. Rhodes, T., Stimson, G. V., Crofts, N., Ball, A., Dehne, K. L., and Khodakevich, L. (1999). Drug Injecting, rapid HIV spread and the 'risk environment' AIDS, 13, S259-S269.
54. Rhodes, T. (2002). The 'risk environment': A framework for understanding and reducing drug-related harm. The International Journal of Drug Policy, 13, 85-94.
55. Rhodes, T., Mikhailova, L., Sarang, A., Lowndes, C. M., Rylkov, A., Khutorskoy, M., and Renton, A. (2003). Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: A qualitative study of micro risk environment. Social Science and Medicine, 57, 39-54.
56. Rothenberg, R., Woodhouse, D. E., Potterat, J. J., Muth, S. Q., Darrow, W. W., and Klovdahl, A. S. (1995). Social networks in disease transmission: The Colorado Springs study. In R. H. Needle, S. L. Coyle, S. G. Genser, and R. T. Trotter II (Eds.). Social networks, drug abuse and HIV transmission (pp. 3-19). Rockville, MD: National Institute on Drug Abuse.
57. Singer, M., Jia, Z., Schensul, J., Weeks, M., and Page, J. B. (1992). AIDS and the IV drug user: The local context in prevention efforts. Medical Anthropology, 14, 285-306.
58. Singer, M., Stopka, T., Siano, C., Springer, K., Barton, G., Khoshnood, K., Gory de Puga, and Heimer, R. (2000). The social geography of AIDS and hepatitis risk: Qualitative approaches for assessing local differences in sterile-syringe access among injection drug users. American Journal of Public Health, 90, 1049-1056.
59. Stark, K., Muller, R., Bienzle, U., and Guggenmoos-Holzmann, I. (1996). Frontloading: A risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin. AIDS, 10, 311-317.
60. Thorpe, L. E., Quellet, L. J., Hershow, R., Bailey, S. L., Williams, I. T., Williamson, J., Monterroso, E. R., and Garfein, R. S. (2002). Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. American Journal of Epidemiology, 155, 645-653.
61. Trotter, R. T. II, Rothenberg, R. B. and Coyle, S. (1995). Drug abuse and HIV prevention research: Expanding paradigms and network contributions to risk reduction. Connections, 18, 29-45.
62. Wallace, R. (1990) Urban desertification, public health and public disorder: "Planned shrinkage", violent death, substance abuse and AIDS in the Bronx. Social Science and Medicine, 31, 801-813.
63. Watters, J., and Biernacki, P. (1989). Targeted sampling: Options for the study of hidden populations. Social Problems, 36, 416-430.
64. Weeks, M. R., Clair, S., Singer, M., Radda, K., Schensul, J. J., Wilson, D. S., Martinez, M., Scott, G. and Knight, G. (2001). High risk drug use sites, meaning and practice: Implications for AIDS prevention. Journal of Drug Issues, 31, 781-808.
65. Weeks, M. R., Clair, S., Borgatti, S. P., Radda, K., and Schensul, J. J. (2002). Social networks of drug users in high risk sites: Finding the connections. AIDS and Behavior, 6, 193-206.
66. Zule, W. A. (1992). Risk and reciprocity: HIV and the injection drug user. Journal of Psychoactive Drugs, 24, 243-249.